Andrew Mendelawitz chatted with South African pharmacist Ian Lee about his experience catching Covid-19 and using broad-spectrum...

Introduction The urgency of the COVID-19 problem (CoronaVirus Disease 2019) is currently beyond doubt. In Russia alone, more than 4.5...

Melbourne-based pharmaceutical company Pharmachal Health Group is hailing COVID-19 drug TRIAZAVIRIN™ – otherwise known as TZV – as a...

Pharmachal sat down with Michael van Cuylenburg, Director of the Ricard Group to talk about the company, its technology and its pathway...

Melbourne pharmaceutical company Pharmachal Health Group has secured regional distribution for the novel, broad-spectrum antiviral...

Pharmachal is pleased to present a new corporate presentation to kick of the financial year. Click below to download the presentation.

Pharmachal Health Group has elected to list on the SSX as a stepping-stone towards listing on a major international exchange. Charles...

MELBOURNE, TUESDAY 30 MARCH, 2021: Pharmachal Health Group (“PHG” or “Company”) is pleased to announce the achievement of a series of...

Pharmachal Health Group is a Melbourne-based pharmaceutical company with a certified globally-patented mini-emulsion drug-in-oil delivery...

Pharmachal Health Group has developed a new means of administering medical cannabis to patients. Pharmachal’s Oromed-Can uses the...

Pharmachal Health Group’s NOPAYNE mini-emulsion lidocaine spray is currently being used in two hospitals in Guatemala, following the...

8 August, 2018 When the Volcan de Fuego (Fire Volcano) in Guatemala erupted in June, over 100 people died, another two hundred went...